Distinct characteristics of heregulin signals mediated by HER3 or HER4

Journal of Cellular Physiology

Volumn 173, Issue 2, 1997, Pages 187-195

  Ulrich Weiss F ^a   Wallasch, Christian ^a   Campiglio, Manuela ^a   Issing, Wolfgang ^b   Ullrich, Axel ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; PROTEIN KINASE;

ANIMAL CELL; CARCINOMA CELL; CELL CULTURE; CELL LINE; CELL TRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY;

3T3 CELLS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; DIMERIZATION; ENZYME ACTIVATION; GLYCOPROTEINS; HUMANS; LIGANDS; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TYROSINE;

EID: 1842289146     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199711)173:2<187::AID-JCP19>3.0.CO;2-D     Document Type: Conference Paper

References (45)

1. Lax, I., Bellot, F., Howk, R., Ullrich, A., Givol, D., and Schlessinger, J. (1989) Functional analysis of the ligand binding domain of EGFR utilizing chimeric human/chicken receptor molecules. EMBO J., 8:421-427.
2. Wallasch, C., Weiss, F.U., Niederfellner, G., Jallal, B., Issing, W., and Ullrich, A. (1995) Heregulin-dependent regulation of HER2/ neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14:4267-4275.
3. Redemann, N., Holzmann B., von Rüden, T., Wagner, E.F., Schlessinger, J., and Ullrich, A. (1992) Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol. Cell. Biol., 12:491-498.
4. Miller, A.D., and Buttimore, C. (1986) Redesign of retrovirus packaging cell lines to avoid recombiantion leading to helper virus production. Mol. Cell. Biol., 6:2895-2902.
5. Chen, C., and Okoyama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7:2745-2752.
6. Yarden, Y., and Ullrich, A. (1988) Growth factor receptor tyrosine kinases. Annu. Rev. Biochem., 57:443-478.
7. Prigent, S.A., and Lemoine, N.R. (1992) The type I (EGFR-related) family of growth factor receptors and their ligands. Prog. Growth Factor Res., 4:1-24.
8. erbB4. Nature, 366:473-475.
9. Tzahar, E., Levkowitz, G., Karunagaran, D., Luo, Y., Peles, E., Lavi, S., Chang, D., Liu, N., Yayon, A., Wen, D., and Yarden, Y. (1994) ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all NDF/Heregulin isoforms. J. Biol. Chem., 269:25226-25233.
10. Sliwkowski, M.X., Schaefer, G., Akita, R.W., Lofgren, J.A., Fitzpatrick, V.D., Nuijens, A., Fendly, B.M., Cerione, R.A., Vandlen, R.L., and Carraway, K.L. III (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 269:14661-14665.
11. Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A., and Press, M.F. (1989) Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244:707-712.
12. Kraus, M.H., Fedi, P., Starks, P., Muraro, P., and Aaronson, S.A. (1993) Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc. Natl. Acad. Sci. USA, 90:2900-2904.
13. Rajkumar, T., and Gullick, W.J. (1994) The type I growth factor receptors in human breast cancer. Breast Cancer Res. Treat. (Netherl.), 29:3-9.
14. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., and McGuire, W.L. (1987) Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235:177-182.
15. erbB2. Science, 256:1205-1210.
16. Wen, D., Peles, E., Cupples, R., Suggs, S.V., Bacus, S.S., Luo, Y., Trail, G., Hu, S., Silbiger, S.M., Levy, R.B., et al. (1992) Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell, 69:559-572.
17. Ben-Baruch, N., and Yarden, Y. (1994) Neu differentiation factors: A family of alternatively spliced neuronal and mesenchymal factors. P.S.E.B.M., 206:221-227.
18. Meyer, D., and Birchmeier, C. (1995) Multiple essential functions of neuregulin in development. Nature, 378:386-390.
19. Marte, B.M., Graus-Porta, D., Jeschke, M., Fabbro, D., Hynes N.E., and Taverna, D. (1995) NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene, 10:167-175.
20. Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Hynes, N.E., and Yarden, Y. (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer. EMBO J., 15:254-264.
21. Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., Di Fiore, P.P., and Kraus, M.H. (1995) Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene, 10:1813-1821.
22. Bacus, S.S., Gudkov, A.V., Zelnick, C.R., Chin, D., Stern, R., Stancovski, I., Peles, E., Ben-Baruch, N., Farbstein, H., Lupu, R., Wen, D., Sela, M., and Yarden, Y. (1993) Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: Implications for mammary tumors. Cancer Res., 53:5251-5261.
23. Pinkas-Karmarski, R., Eilam, R., Spiegler, O., Lavi, S., Liu, N., Chang, D., Wen, D., Schwartz, M., and Yarden, Y. (1994) Brain neurons and glial cells express Neu differentiation factor/heregulin: A survival factor for astrocytes. Proc. Natl. Acad. Sci. USA, 91:9378-9391.
24. Falls, D.L., Rosen, K.M., Corfas, G., Lane, W.S., and Fischbach, G.D. (1993) ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell, 72:801-815.
25. Jo, S.A., Zhu, X., Marchionini, M.A., and Burden, S.J. (1995) Neu-regulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature, 373:158-161.
26. neu stimulates tyrosine phosphorylation in vivo. Mol. Cell. Biol., 8:3969-3973.
27. King, C.R., Borello, F., Bellot, F., Comoglio, P., and Schlessinger, J. (1988) Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J., 7:1647-1651.
28. Goldman, R., Levy, R.B., Peles, E., and Yarden, Y. (1990) Heterodimerization of the erbB-1 and erbB-2 receptors in human carcinoma cells: A mechanism for receptor transregulation. Biochemistry, 29:11024-11028.
29. Soltoff, S.P., Carraway K.L. III, Prigent, S.A., Gullick, W.G., and Cantley, L.C. (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol., 14:3550-3558.
30. Plowman, G.D., Culouscou, J.M., Whitney, G.S., Green, J.M., Carlton, G.W., Foy, L., Neubauer, M.G., and Shoyab, M. (1993) Ligand-specific activation of HER4/p180erbB4, a fourth member of the EGF-receptor family. Proc. Natl. Acad. Sci. USA, 90:1746-1750.
31. Guy, P.M., Platko, J.V., Cantley, C., Cerione, R.C., and Carraway K.L. III (1994) Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. USA, 91:8132-8136.
32. Zhang, K., Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A., and Yoshinaga, S.K (1996) Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem., 271:3884-3890.
33. Libermann, T.A., Nusbaum, H.R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M.D., Ullrich, A., Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature, 313:144-147.
34. Yamamoto, T., Kamata, N., Kawano, H., Shimizu, S., Kuroki, T., et al. (1986) High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res., 46:414-416.
35. Kraus, M.H., Issing, W., Miki, T., Popescu, N.C., and Aaronson, S.A. (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA, 86:9193-9197.
36. Chen, X., Levkowitz, G., Tzahar, E., Karunagaran, D., Lavi, S., Ben-Baruch, N., Leitner, O., Ratzkin, B.J., Bacus, S.S., and Yarden, Y. (1996) An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. J. Biol. Chem., 271:7620-7629.
37. Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B.J., Sela, M., and Yarden, Y. (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15:2425-2467.
38. Qian, X., Dougall, W.C., Hellman, M.E., and Greene, M.I. (1994) Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation. Oncogene, 9:1507-1514.
39. Decker, S.J. (1993) Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites. J. Biol. Chem., 264:9176-9179.
40. Cohen, B.D., Green, J.M., Foy, L., and Fell, H.P. (1996) HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers. J. Biol. Chem., 271:4813-4818.
41. Beerli, R.R., and Hynes, N.E. (1996) Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem., 271:3884-3890.
42. Riese, D.J., Bermingham, Y., van Raaij, T.M., Buckley, S., Plowmann, G.D., and Stern, D.F. (1996) Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-b. Oncogene, 12:345-353.
43. Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., and Lemke, G. (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature, 378:390-394.
44. Lee, K.-F., Simon, H., Chen, H., Bates, B., Hung, M.-C., and Hauser, C. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature, 378:394-398.
45. Traverse, S., Gomez, N., Paterson, H., Marshall, C., and Cohen, P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells: Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J., 288:351-355.